General Range
FORLIC DS
Price on request/100 · MOQ 100 boxes
FORLIC DS Dry Syrup by Fortune Labs contains Amoxicillin and Potassium Clavulanate, a combination antibiotic formulated for treating susceptible bacterial infections in children. Amoxicillin is a penicillin-class antibiotic that inhibits bacterial cell wall synthesis, while Potassium Clavulanate helps protect Amoxicillin against certain bacterial resistance enzymes. FORLIC DS may be prescribed for selected respiratory tract infections, ear infections, sinusitis, urinary tract infections, and skin infections when clinically appropriate. Its oral suspension formulation provides a convenient administration option for pediatric patients. Available in dry syrup packaging with water for reconstitution, FORLIC DS is part of Fortune Labs' pediatric pharmaceutical portfolio. Contact Fortune Labs for Pediatric PCD Pharma Franchise opportunities, wholesale pricing, product availability, and distribution enquiries across India. Use only as prescribed.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Amoxicillin + Potassium Clavulanate Oral Suspension IP (typically 400 mg + 57 mg per 5 ml
- Packaging Type
- Dry Syrup Bottle with Outer Carton and Water for Reconstitution
- Packaging Size
- 30 ml
- Dosage Form
- Oral Suspension
- Treatment
- Bacterial respiratory tract infections, throat infections, ear infections, sinusitis, urinary tract infections, and certain skin and soft tissue infec
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
